Latest News

Investors may be asking whether Omega Healthcare Investors at US$47.90 still offers value after a strong run, or if they might be late to the story. The stock is slightly down 0.9% over the past week, while returns sit at 3.2% over 30 days, 7.6% year to date, 40.8% over 1 year and 94.8% over 5 years. This mix often prompts investors to revisit what they are really paying for. Recent coverage has focused on Omega Healthcare Investors as a healthcare focused REIT, with attention on how its...

While Shriram Properties Limited ( NSE:SHRIRAMPPS ) might not have the largest market cap around , it received a lot of...

Nordson (NDSN) has drawn fresh attention after reporting second quarter earnings and updating guidance, combining higher sales and earnings with increased full year and third quarter revenue expectations, supported by stronger backlog and order momentum. See our latest analysis for Nordson. The recent earnings beat and higher guidance appear to be feeding into sentiment, with Nordson’s share price up 4.75% over the past week and delivering a 52.01% 1 year total shareholder return, while the...

On May 19, 2026, Addus HomeCare director Esteban Lopez sold 250 shares of common stock in an open-market transaction at US$93.00 per share, leaving him with a remaining direct holding of roughly 3,200–3,450 shares disclosed in recent SEC Form 4 filings. At the same time, analysts highlight that Addus HomeCare may benefit from regulatory pressure on self-directed operators and an aging U.S. population, potentially widening its opportunity to acquire client books and grow its home-care...

NOW Corporation (PSE:NOW) has drawn fresh attention after recent trading left the stock unchanged on the day and up 33.33% over the past week, prompting investors to reassess its telecoms and IT exposure. See our latest analysis for NOW. The strong 33.33% 7 day share price return at ₱0.64 comes after a mixed run, with the 30 day share price return of 14.29% contrasting with a year to date share price return that is down 8.57%, while the 1 year total shareholder return of 64.10% sits against...

Roivant Sciences (NasdaqGS:ROIV) has filed a shelf registration that would allow it to issue nearly $1 billion in new common shares. The filing provides the company with flexibility to conduct future equity offerings when market conditions and funding needs align. This potential issuance could affect shareholder dilution, capital raising plans, and Roivant's ability to fund future projects. Roivant Sciences enters this development with its share price at $29.96 and very large multi-year...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

The recent earnings posted by Alkhorayef Water and Power Technologies Company ( TADAWUL:2081 ) were solid, but the...

Investors were disappointed with the weak earnings posted by Jahez International Company for Information Systems...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Deutsche Lufthansa (XTRA:LHA) has appointed Dr. Johannes Teyssen as chair of its supervisory board. The appointment brings in leadership experience from his prior executive roles, including at BP. This change marks a fresh corporate governance development for the airline group. For investors watching XTRA:LHA, the change at the top of the supervisory board comes as the stock trades around €8.172. Over the past month, the share price is up 12.7%, while the past year shows a 27.1% gain and a...

CSPC Pharmaceutical Group (SEHK:1093) has recently secured Chinese approvals for Enyike, a ustekinumab biosimilar, and 4mg budesonide enteric-coated capsules, broadening its autoimmune and nephrology treatment offerings for patients. See our latest analysis for CSPC Pharmaceutical Group. At a latest share price of HK$7.69, the stock has seen a 1-day share price return of 4.77% and a 7-day share price return of 1.45%, but a 90-day share price return that is down 23.56%. The 1-year total...

Predictive Discovery Limited has reported its third-quarter and nine-month results to March 31, 2026, posting net losses of A$8.99 million and A$21.87 million respectively, with basic and diluted loss per share of A$0.0035 for the quarter and A$0.008 for the nine-month period. These results underline that Predictive Discovery remains in a loss-making phase as it advances its West African gold assets toward fuller operational and financial maturity. We will now examine how the latest...

Pattern Group (NasdaqGS:PTRN) received a key U.S. patent for its True ROAS advertising measurement technology, covering how it tracks and attributes advertising effectiveness. The company also launched Pi, an AI powered autonomous ecommerce execution engine built on its proprietary data and retail expertise. These developments expand Pattern Group's adtech and ecommerce tools for brand partners and may influence how investors view its technology and growth approach. Pattern Group focuses on...

G Mining Ventures (TSX:GMIN) is back in focus after releasing first quarter 2026 results, along with detailed production guidance that outlines expected gold output levels and projected cost trends through 2027. See our latest analysis for G Mining Ventures. The recent guidance reaffirmation and first quarter results came after a choppy few months for the stock, with the 30 day share price return down 14.4% and the 90 day share price return down 16.2%. Even so, the 1 year total shareholder...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

As the Australian market anticipates a modest rise, buoyed by hopes of a peaceful resolution in Iran and upcoming economic data releases, investors are keeping a close eye on emerging opportunities. Penny stocks, despite their somewhat outdated moniker, continue to intrigue those seeking affordable entry points with potential for growth. These smaller or newer companies can offer unique value propositions when backed by strong financials, and we'll explore several promising candidates that...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Cooling Treasury yields and progress in Iran peace talks eased inflation worries on Tuesday, lifting investor appetite for discretionary stocks and putting fresh attention on Columbia Sportswear (COLM) after its 3% afternoon move. See our latest analysis for Columbia Sportswear. That 3.3% one day share price move fits into a broader pattern where Columbia Sportswear has a 7 day share price return of 7.13% and a year to date share price return of 13.14%. This comes even as the 3 year total...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...